Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Olaratumab Intravenous
Determining the interaction of Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Olaratumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Oleptro
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Oleptro Oral
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Olmesartan
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Olmesartan and Hydrochlorothiazide
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Olmesartan Medoxomil
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Olmesartan Medoxomil and Hydrochlorothiazide
- Olaratumab Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Olaratumab Intravenous-Kitabis Pak
- Olaratumab Intravenous-Kitabis Pak inhalation
- Olaratumab Intravenous-Klofensaid II
- Olaratumab Intravenous-Klonopin
- Olaratumab Intravenous-Klonopin Wafer